Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 19 or older who have been diagnosed with locally advanced or metastatic non-small cell lung cancer (a type of lung cancer) that has tested positive for a specific genetic marker called ROS1, confirmed through a tissue or cell sample.
- People aged 12 or older who have any solid tumour (a type of cancer that forms a distinct mass) that carries a specific genetic change called an NTRK gene fusion.
- People whose cancer has been confirmed to have a ROS1 or NTRK 1-3 gene fusion through an approved local test.
- People who are able and willing to provide written informed consent to participate.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have been treated with the drug repotrectinib for a reason that has not been officially approved in Korea.
- People who have been treated with repotrectinib at a dose that has not been officially approved in Korea.
- People for whom repotrectinib is listed as unsuitable or unsafe according to the official prescribing guidelines set by Korea's medicine regulatory authority (the MFDS).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants experiencing adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.